Publicacións en colaboración con investigadores/as de University of Groningen (34)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective

    European Journal of Nuclear Medicine and Molecular Imaging

  3. Realization and dosimetric characterization of a mini-beam/flash electron beam

    Frontiers in Physics, Vol. 11

2022

  1. Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome A Comprehensive Analysis of 58 Cases

    American Journal of Surgical Pathology, Vol. 46, Núm. 6, pp. 765-773

  2. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET

    Journal of Controlled Release, Vol. 347, pp. 500-507

  3. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

    Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842

  4. Impact of an Adenosine A2AReceptor Agonist and Antagonist on Binding of the Dopamine D2Receptor Ligand [11C]raclopride in the Rodent Striatum

    Molecular Pharmaceutics, Vol. 19, Núm. 8, pp. 2992-3001

  5. Meta-analysis of epigenome-wide association studies in newborns and children show widespread sex differences in blood DNA methylation

    Mutation Research - Reviews in Mutation Research, Vol. 789

  6. Nanomolar resveratrol reduces early alterations of pancreatitis and pancreatic cancer in pancreatic acinar cells

    Phytomedicine Plus, Vol. 2, Núm. 3

  7. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. A new approach to produce [18F]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  2. Breast cancer risk genes - Association analysis in more than 113,000 women

    New England Journal of Medicine, Vol. 384, Núm. 5, pp. 428-439

  3. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  4. Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 12, pp. 4105-4106

  5. Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 13, pp. 4307-4317

  6. In Vivo Induction of P-Glycoprotein Function can be Measured with [18F]MC225 and PET

    Molecular Pharmaceutics, Vol. 18, Núm. 8, pp. 3073-3085

  7. Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates

    Molecular Pharmaceutics, Vol. 18, Núm. 1, pp. 416-428

  8. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Biomedical Research Programs at Present and Future High-Energy Particle Accelerators

    Frontiers in Physics, Vol. 8

  2. PET imaging of ABC transporters at the blood-brain barrier

    PET and SPECT of Neurobiological Systems (Springer International Publishing), pp. 809-850